Samuel Litwin

1.7k total citations
32 papers, 1.4k citations indexed

About

Samuel Litwin is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Samuel Litwin has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Samuel Litwin's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Samuel Litwin is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Samuel Litwin collaborates with scholars based in United States and Canada. Samuel Litwin's co-authors include Robert L. Comis, Peter J. O’Dwyer, C McAleer, P F Engstrom, Corey J. Langer, John Leighton, R F Ozols, Margie L. Clapper, Perry Watts and Mark J. Shlomchik and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Samuel Litwin

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Litwin United States 19 540 490 297 286 165 32 1.4k
S. E. Salmon United States 19 949 1.8× 625 1.3× 183 0.6× 162 0.6× 215 1.3× 43 1.8k
Alberts Ds United States 19 486 0.9× 517 1.1× 130 0.4× 80 0.3× 90 0.5× 53 1.3k
Yoshimune Shiratori Japan 24 322 0.6× 637 1.3× 174 0.6× 493 1.7× 156 0.9× 65 1.9k
WN Hittelman United States 19 597 1.1× 900 1.8× 171 0.6× 82 0.3× 150 0.9× 39 1.9k
H.H. Sedlacek Germany 20 485 0.9× 596 1.2× 153 0.5× 287 1.0× 225 1.4× 69 1.3k
Gregory Sivolapenko Greece 19 351 0.7× 355 0.7× 154 0.5× 813 2.8× 221 1.3× 57 1.4k
K. C. Anderson United States 20 440 0.8× 670 1.4× 112 0.4× 228 0.8× 453 2.7× 38 1.6k
David Friedland United States 20 489 0.9× 545 1.1× 486 1.6× 87 0.3× 96 0.6× 60 1.5k
Sriram Subramaniam United States 16 694 1.3× 366 0.7× 412 1.4× 151 0.5× 330 2.0× 27 1.4k
Susan Ellard Canada 27 968 1.8× 823 1.7× 964 3.2× 380 1.3× 136 0.8× 81 2.4k

Countries citing papers authored by Samuel Litwin

Since Specialization
Citations

This map shows the geographic impact of Samuel Litwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Litwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Litwin more than expected).

Fields of papers citing papers by Samuel Litwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Litwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Litwin. The network helps show where Samuel Litwin may publish in the future.

Co-authorship network of co-authors of Samuel Litwin

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Litwin. A scholar is included among the top collaborators of Samuel Litwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Litwin. Samuel Litwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharkey, Robert M., Habibe Karacay, Samuel Litwin, et al.. (2009). Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma. Journal of Nuclear Medicine. 50(3). 444–453. 44 indexed citations
2.
Sharkey, Robert M., Habibe Karacay, Samuel Litwin, et al.. (2008). Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody. Cancer Research. 68(13). 5282–5290. 60 indexed citations
3.
Lewis, Nancy, Richard M. Scher, James M. Gallo, et al.. (2002). Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed. Cancer Chemotherapy and Pharmacology. 50(4). 257–265. 5 indexed citations
4.
Movsas, Benjamin, Richard Hudes, Elizabeth Rosvold, et al.. (2001). Induction and Concurrent Paclitaxel/Carboplatin Every 3 Weeks with Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: An Interim Report. Clinical Lung Cancer. 3(2). 125–132. 7 indexed citations
5.
Adams, Gregory P., Calvin Shaller, Lara L. Chappell, et al.. (2000). Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules. Nuclear Medicine and Biology. 27(4). 339–346. 73 indexed citations
6.
Stewart, Jeffrey J, Saleh Ibrahim, Perry Watts, et al.. (1997). A Shannon entropy analysis of immunoglobulin and T cell receptor. Molecular Immunology. 34(15). 1067–1082. 143 indexed citations
7.
Clapper, Margie L., Christine E. Szarka, Gordon R. Pfeiffer, et al.. (1997). Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity.. PubMed. 3(1). 25–30. 33 indexed citations
8.
O'Dwyer, P J, Christine E. Szarka, Kang-Shen Yao, et al.. (1996). Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.. Journal of Clinical Investigation. 98(5). 1210–1217. 73 indexed citations
9.
Clark, Joseph I., Samuel Litwin, R. Katherine Alpaugh, et al.. (1996). Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.. PubMed. 56(1). 113–20. 5 indexed citations
10.
Langer, Corey J., John Leighton, Robert L. Comis, et al.. (1995). Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.. Journal of Clinical Oncology. 13(8). 1860–1870. 252 indexed citations
11.
Hietala, Oili A., Susan K. Gilmour, Samuel Litwin, et al.. (1995). Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.. PubMed. 1(6). 665–71. 6 indexed citations
12.
O'Dwyer, P J, et al.. (1993). Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide. British Journal of Cancer. 68(4). 756–766. 6 indexed citations
13.
O’Dwyer, Peter J., Russell J. Schilder, Margie L. Clapper, et al.. (1991). Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.. PubMed. 51(22). 6059–65. 124 indexed citations
14.
Hoffman, John P., Joseph F. Kusiak, Marcia Boraas, et al.. (1991). Risk factors for immediate prosthetic postmastectomy reconstruction.. PubMed. 57(8). 514–21; discussion 522. 15 indexed citations
15.
Hietala, Oili A., Kevin O’Donnell, Christopher P. Holroyde, et al.. (1990). Properties of ornithine decarboxylase in human colorectal adenocarcinomas.. PubMed. 50(7). 2088–94. 23 indexed citations
16.
Krigel, Robert L., Kristin Padavic‐Shaller, Alfred R. Rudolph, et al.. (1988). A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.. PubMed. 48(13). 3875–81. 43 indexed citations
17.
Moldofsky, Philip J., et al.. (1988). Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.. PubMed. 48(9). 2568–73. 49 indexed citations
18.
Murphy, Scott, Samuel Litwin, P. Koch, et al.. (1982). Indications for platelet transfusion in children with acute leukemia. American Journal of Hematology. 12(4). 347–356. 105 indexed citations
19.
Lustbader, Edward D. & Samuel Litwin. (1981). Design of Censored Survival Studies. Biometrics. 37(4). 697–697. 4 indexed citations
20.
Dorus, Elizabeth, et al.. (1976). Height and Personality Characteristics of 47, XYY Males in a Sample of Tall Non-Institutionalized Males. The British Journal of Psychiatry. 129(6). 564–573. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. E. Salmon Breakdown of academic impact, for papers by Alberts Ds Breakdown of academic impact, for papers by Yoshimune Shiratori Breakdown of academic impact, for papers by WN Hittelman Breakdown of academic impact, for papers by H.H. Sedlacek Breakdown of academic impact, for papers by Gregory Sivolapenko Breakdown of academic impact, for papers by K. C. Anderson Breakdown of academic impact, for papers by David Friedland Breakdown of academic impact, for papers by Sriram Subramaniam Breakdown of academic impact, for papers by Susan Ellard
Rankless by CCL
2026